Leveraging Existing Resources to Meet the Challenges Faced by People Who Use Drugs or Who Have Substance Use Disorders During the COVID-19 Pandemic
Click here to view the recording with the integrated audio transcript using the password below. external icon
The fully captioned video and edited transcript will be posted within the next few days.
This COCA Call will be held on Friday, March 27, 2020
The COVID-19 pandemic has presented challenges in healthcare for those who may be at greater risk for adverse health outcomes such as people who use drugs or people who have a substance use disorder. To better facilitate provision of care, the Centers for Disease Control and Prevention (CDC) has organized this COCA Call to help improve understanding among clinicians of the concerns of people who use drugs and people who have a substance use disorder. This COCA Call will feature speakers from CDC, the Substance Abuse and Mental Health Services Administration (SAMHSA), and the American Society for Addiction Medicine (ASAM).
During this COCA Call, subject matter experts will highlight existing resources and exceptions for clinicians who prescribe medications for opioid use disorder, increase awareness of existing community-based linkage to care resources, and discuss the outpatient telemedicine experience from a front-line provider perspective.
Neeraj Gandotra, MD
Chief Medical Officer
Substance Abuse and Mental Health Services Administration
Cherie Rooks-Peck, PhD
Lead, Applied Prevention Science Team
Prevention Programs and Evaluation Branch
Division of Overdose Prevention
Centers for Disease Control and Prevention
Shawn Ryan, MD, MBA
President & Chief Medical Officer, BrightView Health
Emergency & Addiction Medicine
Committee Chair, American Society for Addiction Medicine Legislation
Due to the high demand we anticipate for this COCA Call, we encourage participants to consider viewing on Facebook. To see the call live, please click on COCA’s Facebook Page.
Thursday, October 22, 2020,
2:00 PM – 3:00 PM ET
US: +1 669 254 5252
or +1 646 828 7666
International numbersexternal icon
US: +16692545252,,1616039348# or +16468287666,,1616039348#
Webinar ID: 160 928 8166Add to Calendar
“This content and conclusions are those of the author and presenter and do not necessarily represent the views of, nor should any endorsements be inferred by, the Centers for Disease Control and Prevention.”
Advanced registration is not required.
Date: Thursday, October 22, 2020
Time: 2:00 PM – 3:00 PM ET
A few minutes before the webinar begins, please click the link below to join:
Webinar ID: 160 928 8166
Dial-in US: +1 669 254 5252 or +1 646 828 7666
iPhone one-tap: US: +16692545252,,1609288166# or +16468287666,,1609288166#
International numbers available: https://www.zoomgov.com/u/acjVLrtzhIexternal icon
At the conclusion of the session, the participant will be able to accomplish the following—
- Cite several flexible resources available to providers to ensure continuity of care during the COVID-19 pandemic.
- Explain CDC strategies and activities to prevent opioid overdoses and related harms, including CDC overdose prevention resources.
- Discuss the impact of COVID-19 Pandemic on the opioid crisis and CDC’s implemented solutions.
COCA Call Objectives
- Cite background information on the topic covered during the presentation.
- Discuss CDC’s role in the topic covered during the presentation.
- Describe the topic’s implications for clinicians.
- Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
- Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of health care providers.
To receive continuing education (CE) for WC2922-102220—Clinician Outreach and Communication Activity (COCA) Calls/Webinars—Leveraging Existing Resources to Meet the Challenges Faced by People Who Use Drugs or Who Have Substance Use Disorders During the COVID-19 Pandemic, Thursday, October 22, 2020, please visit TCEO and follow these 9 Simple Steps by Monday, November 23, 2020.
To receive continuing education (CE) for WD2922-102220—Clinician Outreach and Communication Activity (COCA) Calls/Webinars—Leveraging Existing Resources to Meet the Challenges Faced by People Who Use Drugs or Who Have Substance Use Disorders During the COVID-19 Pandemic, Tuesday, November 24, 2020, (Web on Demand), please visit TCEO and follow these 9 Simple Steps by Thursday, November 24, 2022.
CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides 1.0 contact hour.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This program is a designated event for pharmacists to receive) 0.1 CEUs in pharmacy education. The Universal Activity Number is JA4008229-0000-20-055-L04-P and enduring JA4008229-0000-20-056-H04-P course category.
This activity has been designated as Knowledge-Based.
Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.
In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters.
Planners have reviewed content to ensure there is no bias.
The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept commercial support for this continuing education activity.
- Physician Assistants
- Health Educators
- Other Clinicians
- Contact Information:email@example.com
- Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communication Branch
- Method of Participation:You may participate in the educational activity by viewing the program information above.